We feel it’s important to maintain a high level of thought leadership in our field, providing insight and guidance to the health science domain in order to better serve the interests of our customers and, ultimately, patients.
Aridhia's DARE UK TREvolution final report: federated TRE workspace integration, GA4GH Task Execution Service implementation, and Federated Node development.
DOI: 10.5281/zenodo.19206117
This paper scores the Aridhia DRE against the four sections of the SATRE specification for 2026.
This interim report details initial work carried out by Aridhia under the DARE UK TREvolution project.
DOI: 10.5281/zenodo.17573488
How consortium-based drug development programmes achieve regulatory milestones. Lessons from C-Path, IHI, and the RDCA-DAP platform built on the Aridhia DRE.
DOI: 10.1111/cts.70215
How GOSH and Aridhia partnered in 2017 to build a state-of-the-art Digital Research Environment, now supporting 400+ active research and clinical projects.
A beginner's guide for clinical pharmacologists entering rare disease drug development. Published in Clinical and Translational Science, 2025
DOI: 10.1111/cts.70215
MIDD innovations for paediatric rare disease drug development, addressing small populations and patient heterogeneity. Published Clin Pharmacol Ther, 2025
DOI: 10.1002/cpt.3683
How a DRE-enabled patient swarm approach incorporates the patient voice into collaborative QSP model development for Parkinson's disease across academic centres
DOI: 10.1002/jcph.70028
